Rankings
▼
Calendar
LQDA Q4 2025 Earnings — Liquidia Corporation Revenue & Financial Results | Market Cap Arena
LQDA
Liquidia Corporation
$3B
Q4 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$92M
+3054.6% YoY
Gross Profit
$94M
101.7% margin
Operating Income
$20M
21.5% margin
Net Income
$15M
15.8% margin
EPS (Diluted)
$0.15
QoQ Revenue Growth
+69.3%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$42M
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$328M
Total Liabilities
$283M
Stockholders' Equity
$45M
Cash & Equivalents
$191M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$92M
$3M
+3054.6%
Gross Profit
$94M
$2M
+5887.5%
Operating Income
$20M
-$36M
+154.8%
Net Income
$15M
-$38M
+137.9%
Revenue Segments
Product
$90M
95%
Service
$5M
5%
← FY 2025
All Quarters